Enrlich: Chemotherapy is Launched, from "The History of Medicine" / Robert Thom

Actions

About this Item

Record Details

Accession Number
UMHS.39
Title
Enrlich: Chemotherapy is Launched, from "The History of Medicine"
Artist
Robert Thom
Artist Nationality
American
Artist Life Dates
1915-1979
Medium and Support
oil on canvas
Object Creation Date
circa 1952
Object Creation Place
North and Central America (continent)
United States (nation)
Michigan (state)
Creation Place 2
United States (nation)
Creation Place 3
Michigan (state)
Dimensions
92.71 cm x 75.57 cm (36 1/2 in. x 29 3/4 in.)
Century
20th century
Primary Object Classification
Painting
Physical Description
In a crowded laboratory at Frankfurt's Institute of Experimental Therapy, German research scientist Paul Ehrlich (1854-1915) habitually scrawled work orders to associates with stubby colored pencils on "blocks" of note paper. Dr. Ehrlich and his Japanese assistant, Dr. Sahachiro Hata, announced Salvarsan (606) to the world in 1910 as a "chemical bullet" for treatment of syphilis. Dr. Ehrlich's success with chemical synthesis gave impetus to a new medical science, chemotherapy. Though his greatest achievements were in this field, Dr. Ehrlich contributed to many branches of medicine and shared in a 1908 Nobel Prize for his work on immunology.
Rights
If you are interested in using an image for a publication, please visit https://umma.umich.edu/about/services/request-image/ for more information and to fill out the online Image Rights and Reproductions Request Form.

Technical Details

Record
UMHS.39
Link to this Item
https://quod.lib.umich.edu/m/musart/x-umhs.39/umhs.39.jpg

Rights and Permissions

Cite this Item

View the Help Guide for more information.

Full citation
"Enrlich: Chemotherapy is Launched, from "The History of Medicine"; Robert Thom." In the digital collection University of Michigan Museum of Art. https://quod.lib.umich.edu/m/musart/x-umhs.39/umhs.39.jpg. University of Michigan Library Digital Collections. Accessed March 28, 2024.
Do you have questions about this content? Need to report a problem? Please contact us.